Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions 2024-08-19 21:00
Health In Tech Partners with NovaNet and Tall Tree to Host Webinar on the Latest Strategies for Personalizing Client Health Coverage 2024-08-19 20:30
China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 2024-08-19 20:00
De Motu Cordis (DMC) Applauds ARS Pharma's FDA Approval of Neffy®, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts 2024-08-16 18:00
Sanyou Bio's Innovative Intelligent Antibody Design oneClick+ Platform is Officially Launched 2024-08-16 06:00
Vimgreen Completes Enrollment of Its Phase 2 Clinical Trial Evaluating VG081821AC for the Treatment of Parkinson's Disease 2024-08-15 21:37
Ivonescimab (PD-1/VEGF) Received Priority Review from China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC 2024-08-15 07:30
Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM" 2024-08-13 20:00
Celltrion USA announces incorporation of adalimumab-aaty, a Humira® biosimilar, to the Costco Member Prescription Program 2024-08-13 07:46
Mabwell's Novel Nectin-4 Targeting ADC 9MW2821 Granted Breakthrough Therapy Designation by China's NMPA 2024-08-12 22:00
VISEN Pharmaceuticals announced that the Phase 3 PaTHway China Trial of Palopegteriparatide achieved primary and key secondary endpoints in the treatment of adults with hypoparathyroidism 2024-08-12 21:00
Actinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trial 2024-08-12 20:30
Milestone: Renal Nerve Mapping / Selective Renal Denervation (msRDN) System by SyMap Medical Ltd Approved for Treatment of Uncontrolled Hypertension in China 2024-08-12 13:55
IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Two New Autoimmune Disease Indications 2024-08-12 13:52
T-MAXIMUM PHARMACEUTICAL Announces Latest Clinical Advances in Allogeneic CAR-T Cell Therapy Breakthrough for Solid Tumors 2024-08-08 20:00
WuXi Biologics and Medigene Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers 2024-08-08 16:00
WestGene to Advance Clinical Trials Following Dual IND Approvals for World's First EB Virus-Related mRNA Therapeutic Cancer Vaccine 2024-08-08 10:59
Concord Medical Regains Compliance with NYSE Minimum Price Requirement 2024-08-07 20:30
Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States 2024-08-07 20:00
I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP (PwC) 2024-08-07 19:00
1 15 16 17 18 19 431